Navigation Links
Medications That Lower Breast Cancer Risk Carry Other Dangers
Date:9/14/2009

Analysis notes tamoxifen, raloxifene can up chances of other cancers, clots

MONDAY, Sept. 14 (HealthDay News) -- Medications given to women at high risk for developing breast cancer do reduce their cancer risk, but the drugs carry other health risks, a new analysis suggests.

That was the conclusion of researchers who looked at numerous published studies, including randomized clinical trials and a head-to-head assessment of the medications used for risk reduction. Those include tamoxifen, raloxifene and tibolone. The third drug is not currently on the U.S. market but is available in other countries, and there is some research on its risk-reduction benefits.

"We found that the three drugs actually did reduce the risk for invasive breast cancer by 30 to 68 percent," said review author Dr. Heidi D. Nelson, a research professor at Oregon Health & Science University. The report is published in the Sept. 15 issue of the Annals of Internal Medicine.

While the medications provided similar reductions in breast cancer risk, each carries its own level of side effects. "They did differ on the harm side," Nelson said. "That's important to know."

The use of the drugs to reduce breast cancer risk in healthy, high-risk women is not as common, Nelson noted, as their use to prevent recurrence in women already diagnosed with and treated for breast cancer. For instance, tamoxifen has been used for years to lower the chances of recurrence among breast cancer survivors. Recently, however, other researchers found tamoxifen only lowers the risk of a more common type of breast cancer, called ER-positive, while it raises the risk of developing ER-negative breast cancer, a more aggressive disease, in breast cancer survivors.

A similar story appears to be unfolding when the drugs are used for risk reduction in women who are cancer-free but at high risk of breast cancer. The women may be termed high risk due to ge
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CVS Caremark Data Finds More than 50 Percent of Adults 45-years and Younger are not Adherent to Cholesterol Lowering Medications
2. AUDIO from Medialink and Forest Laboratories: Dangers of Switching Medications
3. New Source of Information on Crohn's Disease and Ulcerative Colitis Medications
4. Update on Astellas Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications
5. Large Majority of Drivers 55 and Older Unaware of Potentially Dangerous Combination of Medications and Driving, Says New AAA Foundation Study
6. Astellas Seeks Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications
7. Chronic and Complex Diseases on the Rise in Philadelphia: Adults Using More Medications to Treat Chronic Conditions
8. Center for Medicines & Healthy Aging(C) and BidRx(R) Partner to Help Consumers Save on Prescription Medications
9. New Source of Information on Psoriasis Medications
10. Easter Seals Applauds Agreement to Cut Costs of Prescription Medications
11. New Source of Information on Pulmonary Hypertension Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... 8, 2014) Researchers from Montefiore Medical Center ... of Yeshiva University will present new findings at ... 12 July 17 in Copenhagen, Denmark. Data from ... prompt transition from cognitive normality to mild cognitive impairment ... Einstein Aging Study , established in 1980 to examine ...
(Date:7/9/2014)... watching World Cup highlights, Brian Williams refreshing old school ... positions on railings. A University of Colorado Cancer Center ... shows that YouTube also allows researchers, journals, and health ... of skin cancer and prevention. , "No matter what ... how we communicate around the world," says Chante Karimkhani, ...
(Date:7/9/2014)... National Institute of Allergy and Infectious Diseases (NIAID), ... launched an early-stage clinical trial of CRS3123, an ... difficile ( C. difficile ) infection. CRS3123 ... that inhibits C. difficile growth while sparing normal ... enroll up to 30 healthy men and women ...
(Date:7/9/2014)... A retrospective study conducted by researchers at Tufts University ... adults with intellectual and developmental disabilities, the likelihood of ... dental care increased. The findings, published in the July/August ... help improve interventions designed to address the oral health ... reviewed the dental records of 107 patients at one ...
(Date:7/9/2014)... older age with kidney and heart disease have raised ... older adults. However, in the first study to look ... of Medicine at the University of Pennsylvania report that ... life expectancy and cardiovascular health as very healthy older ... of the ever increasing organ transplant waitlists, the authors ...
Breaking Medicine News(10 mins):Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:Study of dermatology on YouTube shows new ways science reaches public 2Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3Health News:Penn study finds living kidney donation does not increase risk of death or heart disease for older 2
... natural resource restoration planning process following the BP Deepwater Horizon ... of the Interior (DOI) today announced plans to develop a ... as part of the ongoing Natural Resource Damage Assessment (NRDA). ... scoping meetings in each of the affected Gulf Coast states. ...
... anterior cruciate ligament (ACL) knee reconstruction with a hamstring tendon ... to suffer from pain and mobility issues15 years after surgery, ... Society for Sports Medicine,s Specialty Day in San Diego, California ... results in terms of knee symptoms and function with both ...
... with a mechanical disorder of the hip and can be ... some cases, according to a recent study. The research, conducted ... at the American Orthopedic Society for Sports Medicine 2011 Specialty ... annual meeting of the American Academy of Orthopaedic Surgeons. ...
... Robert Reid realized he gave the same tutorial to ... Was there a way, he wondered, to transform this ... Along with medical student Bryden Magee, Dr. Reid, ... Chair of the Division of Reproductive Endocrinology and Infertility ...
... HealthDay Reporter , FRIDAY, Feb. 18 (HealthDay News) -- Months ... startled to find their artificial joint starts squeaking. Not ... one that squeaks, but those who do are likely to ... new research shows. Fortunately, the squeaks are more of ...
... , FRIDAY, Feb. 18 (HealthDay News) -- Cell ... new British study contends. An analysis of data on ... and 2007 -- when cell phone use was climbing -- ... cancers in men or women, said the University of Manchester ...
Cached Medicine News:Health News:Federal Natural Resource Trustees announce next step in BP Deepwater Horizon spill Gulf restoration 2Health News:Federal Natural Resource Trustees announce next step in BP Deepwater Horizon spill Gulf restoration 3Health News:Hamstring grafts prove more effective in ACL knee reconstruction, study says 2Health News:Common hip disorder can cause sports hernia 2Health News:Common hip disorder can cause sports hernia 3Health News:New educational DVD improves female pelvic exam instruction 2Health News:That Squeaking Sound Might Come From Your New Hip 2Health News:That Squeaking Sound Might Come From Your New Hip 3Health News:British Study Finds No Link Between Cell Phones, Brain Tumors 2
(Date:1/15/2014)... , Jan. 15, 2014  A novel wearable injector slightly larger ... painless for patients to self-inject prescription drugs in the large ... cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... to $220B by 2018, according to analysts.   Many of these ...
(Date:1/14/2014)... Corporation (Nasdaq: LMNX ) today announced that it ... on Monday, February 3, 2014. A press release announcing the ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management ... and financial results for the fourth quarter and twelve months ...
(Date:1/14/2014)... 14, 2014 The Brandeis Medical Center, led by Dr. ... premier and affordable laser tattoo removal experience with the advanced Astanza ... in providing high quality cosmetic services with cutting edge medical technology ... Southern California has seen a dramatic increase in ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... Top plastic surgeon , Dr. David Shafer , ... and body cosmetic surgery simulation at his New York City office. ... mommy makeover , facelift , rhinoplasty and ... http://photos.prnewswire.com/prnh/20111025/NY92188 ) With his creation of the world,s ...
... N.J., Oct. 25, 2011 Omthera Pharmaceuticals, Inc., a ... J. Maines has joined the Company as Vice President ... to Chief Operating Officer, Drs. Ben Machielse, Mr. Maines ... at Omthera.   Mr. Maines brings to ...
Cached Medicine Technology:Top Plastic Surgeon Introduces World's First VECTRA XT 3D Imaging Solution 2Top Plastic Surgeon Introduces World's First VECTRA XT 3D Imaging Solution 3Timothy J. Maines Joins Omthera Pharmaceuticals as Vice President of Quality 2
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
Inquire...
Medicine Products: